Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents: structure-activity relationship studies
- PMID: 12238934
- DOI: 10.1021/jm020207y
Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents: structure-activity relationship studies
Abstract
Synthetic catalytic scavengers of reactive oxygen species (ROS) may have broad clinical applicability. In previous papers, two salen-manganese complexes, EUK-8 and EUK-134, had superoxide dismutase (SOD) and catalase activities and prevented ROS-associated tissue injury. This study describes two series of salen-manganese complexes, comparing catalytic ROS scavenging properties and cytoprotective activities. The compounds vary widely in ability to scavenge hydrogen peroxide, with this activity most influenced by salen ring alkoxy substitution and aromatic bridge modifications. In contrast, all compounds show comparable SOD activities. The most active alkoxy-substituted catalase mimetics protected cultured cells from hydrogen peroxide, and a subset of these were also neuroprotective in a rodent stroke model. Thus, structural modification of the prototype EUK-8 yields compounds with enhanced catalase activity and, in turn, biological effectiveness. This supports the concept that salen-manganese complexes represent a class of SOD and, in particular, catalase mimetics potentially useful against ROS-associated diseases.
Similar articles
-
Structure-activity relationship of 15 different Mn-salen derivatives against free radicals.Drug Chem Toxicol. 2013 Jan;36(1):9-18. doi: 10.3109/01480545.2011.644560. Epub 2012 Jan 21. Drug Chem Toxicol. 2013. PMID: 22263563
-
Salen-manganese complexes: sophisticated tools for the analysis of intercellular ROS signaling pathways.Anticancer Res. 2010 Oct;30(10):3967-79. Anticancer Res. 2010. PMID: 21036710
-
Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury.J Pharmacol Exp Ther. 1998 Jan;284(1):215-21. J Pharmacol Exp Ther. 1998. PMID: 9435181
-
Salen Mn complexes mitigate radiation injury in normal tissues.Anticancer Agents Med Chem. 2011 May 1;11(4):359-72. doi: 10.2174/187152011795677490. Anticancer Agents Med Chem. 2011. PMID: 21453241 Free PMC article. Review.
-
Low molecular weight compounds with transition metals as free radical scavengers and novel therapeutic agents.Cardiovasc Hematol Agents Med Chem. 2010 Jul;8(3):128-46. doi: 10.2174/187152510791698389. Cardiovasc Hematol Agents Med Chem. 2010. PMID: 20438441 Review.
Cited by
-
Experimental antioxidant therapy in ataxia telangiectasia.Clin Med Oncol. 2008;2:431-6. doi: 10.4137/cmo.s535. Epub 2008 May 20. Clin Med Oncol. 2008. PMID: 21892312 Free PMC article.
-
MnTBAP or Catalase Is More Protective against Oxidative Stress in Human Retinal Endothelial Cells Exposed to Intermittent Hypoxia than Their Co-Administration (EUK-134).React Oxyg Species (Apex). 2017;3(7):47-65. doi: 10.20455/ros.2017.801. Epub 2017 Jan 1. React Oxyg Species (Apex). 2017. PMID: 29806034 Free PMC article.
-
Amelioration of diet-induced nonalcoholic steatohepatitis in rats by Mn-salen complexes via reduction of oxidative stress.J Biomed Sci. 2012 Feb 29;19(1):26. doi: 10.1186/1423-0127-19-26. J Biomed Sci. 2012. PMID: 22375551 Free PMC article.
-
Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential.Antioxid Redox Signal. 2010 Sep 15;13(6):877-918. doi: 10.1089/ars.2009.2876. Antioxid Redox Signal. 2010. PMID: 20095865 Free PMC article. Review.
-
Insights into Second-Sphere Effects on Redox Potentials, Spectroscopic Properties, and Superoxide Dismutase Activity of Manganese Complexes with Schiff-Base Ligands.ACS Omega. 2019 Jan 2;4(1):48-57. doi: 10.1021/acsomega.8b03018. eCollection 2019 Jan 31. ACS Omega. 2019. PMID: 31459311 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources